Delivery Order SPE2DB22D1106-SPE2DB25FFHR0
- Not listed
- This delivery order, valued at $2,751.58, was awarded on September 8, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count packages). The contract represents a non-competitive, firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $6,147.26 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (50-unit dose packaging) on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ramelteon 8 mg tablets (100-count units) with a contract ceiling value of $3,606.44. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The ultimate completion date is August 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (100-count) with a contract value of $2,035.44. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award involves no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,039.56 to AmerisourceBergen Drug Corp for 30 tablets of Ramelteon 8 mg, a medication used to treat insomnia. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,122 to Amerisourcebergen Drug Corporation. The order is for 30 packages of 8mg Ramelteon tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform as the prime contractor under this order placed against an existing DLA contract vehicle. No set aside designation or...
- The Defense Logistics Agency awarded a delivery order valued at $407.47 to Amerisourcebergen Drug Corporation under an existing prime vendor contract vehicle. The firm fixed price order is for 4561888114 Ramelteon 8 mg tablets to be delivered by August 22, 2023 from the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime contractor without the use of major subcontractors....
- This federal contract award, valued at $1,801.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,698 units of the prescription medication ramelteon 8 mg tablet, with an ultimate completion date of April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $966 to Amerisourcebergen Drug Corporation. The order is for 4561557398 Ramelteon 8 mg tablets to be delivered within a one-day period ending July 21, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation, any set aside designations, or involvement of major subcontractors. The...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHR0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,856.49 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. This delivery order for Ramelteon, a sleep disorder medication, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems. The broader SPE2DX contract vehicle enables AmerisourceBergen to supply a diverse range of pharmaceutical products across multiple therapeutic domains to support military healthcare programs globally, with the company positioned as one of potentially multiple regional contractors under the DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/9/25 |